← Browse by Condition
Medical Condition
advanced ovarian cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1
NCT03878849 Phase 2
Recruiting
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
Enrollment
40 pts
Location
United States
Sponsor
Allarity Therapeutics
NCT06997029 Phase 1
Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Enrollment
234 pts
Location
United States, Denma...
Sponsor
Bristol-Myers Squibb